332 related articles for article (PubMed ID: 16005563)
1. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.
Canda AE; Tuzel E; Mungan MU; Yorukoglu K; Kirkali Z
Eur Urol; 2004 Apr; 45(4):465-9; discussion 469-70. PubMed ID: 15041110
[TBL] [Abstract][Full Text] [Related]
3. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
4. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
[TBL] [Abstract][Full Text] [Related]
7. Superficial urothelial cancer in the prostatic urethra.
Kirkali Z; Canda AE
ScientificWorldJournal; 2006 Feb; 6():2603-10. PubMed ID: 17619737
[TBL] [Abstract][Full Text] [Related]
8. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
[TBL] [Abstract][Full Text] [Related]
10. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
11. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
12. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
[TBL] [Abstract][Full Text] [Related]
13. [Membranous and penile urethral involvement in bladder cancer patients-- review of cystoprostatourethrectomy specimens].
Shimizu T; Suzuki T; Yamanaka H; Satoh J; Suzuki K
Hinyokika Kiyo; 1994 Oct; 40(10):869-72. PubMed ID: 7992699
[TBL] [Abstract][Full Text] [Related]
14. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
15. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.
Sved PD; Gomez P; Nieder AM; Manoharan M; Kim SS; Soloway MS
BJU Int; 2004 Oct; 94(6):785-9. PubMed ID: 15476508
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment for occult malignancy in the prostate before radical cystectomy.
Kefer JC; Voelzke BB; Flanigan RC; Wojcik EM; Waters WB; Campbell SC
Urology; 2005 Dec; 66(6):1251-5. PubMed ID: 16360452
[TBL] [Abstract][Full Text] [Related]
19. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
[TBL] [Abstract][Full Text] [Related]
20. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center.
Chen ME; Pisters LL; Malpica A; Pettaway CA; Dinney CP
J Urol; 1997 Jun; 157(6):2120-3. PubMed ID: 9146596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]